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The evidence for remote patient monitoring Inglis and colleagues provide such evidence through reporting the results of a rigorously conducted meta-analysis of remote patient monitoring through telephone support or telemonitoring. They combined the results from 25 published studies and over 8000 patients to report a statistically signifi cant reduction in mortality with telemonitoring (RR 0.66, p<0.0001) and a non-signifi cant trend to a reduction in mortality with telephone support (RR 0.88, p=0.08). They also report benefi t in terms of hospital readmission, albeit with less impressive effect sizes.
The purpose of remote monitoring
The review set out to test the primary outcome of the effect of remote monitoring on all-cause mortality. Secondary outcomes included length of hospital stay and health-related quality of life. However, the analysis of such outcomes was limited as fewer studies have reported on them, despite being potentially more meaningful patient-centred outcome measures.
Remote patient monitoring may also provide patient benefi t through a reduction in outpatient or primary care visits. It may lead to a greater number of patients being optimised on target doses of heart failure medication and may prompt patients to take their medications and so assist adherence with complex medication regimes. These outcomes are less easily tested in a randomised study design but would provide useful information to guide health service developments.
Who is best suited to remote monitoring?
Consistent with much of the evidence for the management of heart failure, many studies only recruited patients with left ventricular systolic dysfunction. Such patients are on average at least ten years younger than the general heart failure population. As more older patients are likely to have heart failure with preserved left ventricular function, 4 this review largely relates to a subsection of the heart failure patient population.
In addition, the review provides evidence for the effectiveness of remote monitoring in a motivated population of patients who have agreed to participate in randomised trials. A variety of reasons are likely to explain why patients adopt healthcare technology, and future studies should address such issues as well as exploring why patients may not embrace technology.
Implications for clinical practice
The review by Inglis and colleagues has demonstrated that remote monitoring can provide patient benefi t. As such it should be offered alongside home and clinic visits so that the different approaches can be matched to the clinical circumstances and needs of the patient. However, remote monitoring changes the traditional organisation of healthcare, and the speed with which it is adopted may be infl uenced by the way in which it 'fi ts' within existing organisational structures and professional practices and by the attitudes of professionals and patients. 
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